Skip to content
PICO Portalanswers from OpenAlex

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis

PaperCitations, authors & open-access status

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis have?

PICO Portalcitation count

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis has 129 citations in the OpenAlex counts PICO Portal stores.

When was Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis published?

PICO Portalyear

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis has 2013 year in the PICO Portal index.

What is the open-access status of Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

PICO Portaloa status

Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis has bronze oa status in the PICO Portal index.

What is the DOI of Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

PICO Portaldoi

The DOI for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is on the source record.

What is the PMID of Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

PICO Portalpmid

The PMID for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is on the source record.

What is the OpenAlex record for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis?

PICO Portalopenalex

The OpenAlex for Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial